`New Olive Oil Product Treats Pressure Ulcers in High Risk Patients - Olive Oil Times
enEnglish
enEnglishfrFrançaiselελληνικάdeDeutscheitItalianozh-CN中文ptPortuguêsesEspañoltrTürkçehrHrvatskija日本語hiहिंदी
enEnglish
enEnglishfrFrançaiselελληνικάdeDeutscheitItalianozh-CN中文ptPortuguêsesEspañoltrTürkçehrHrvatskija日本語hiहिंदी

New Olive Oil Product Treats Pressure Ulcers in High Risk Patients

By Naomi Tupper
Jun. 20, 2012 10:29 UTC

A new olive oil based prod­uct has recently been patented and is being mar­keted to hos­pi­tals and health cen­tres around Andalusia as a result of a study car­ried out by a team of nurses at the Health Agency of Alto Guadalquivir in Spain over the past two years.

The study was orig­i­nally intended to inves­ti­gate and eval­u­ate the effec­tive­ness of extra vir­gin olive oil in the pre­ven­tion of pres­sure ulcers, a tech­nique that is com­mon in tra­di­tional med­i­cine. It was found that the fatty acids present in extra vir­gin olive oil encour­age regen­er­a­tion of the skin, in addi­tion to increas­ing its hydra­tion, elas­tic­ity and strength.

The oil was also found to reduce skin break­down and there­fore offer pro­tec­tion to areas of skin that were sub­jected to long peri­ods of fric­tion or pres­sure, such as is often present in patients who are con­fined to wheel­chairs or bedrid­den.

The new prod­uct, known as Farmoliva Oleicopiel, is a joint ven­ture between the health agency and the olive oil com­pany Potosi 10 S.A, and was approved last February with an Andalusian research patent.


Farmoliva Oleicopiel

The pub­lic-pri­vate part­ner­ship has gen­er­ated a prod­uct that promises effec­tive treat­ment of pres­sure ulcers, sold in a unique con­tainer that is com­pletely sealed and does not allow the entry of oxy­gen. This pre­vents prod­uct dete­ri­o­ra­tion and ensures it is as effec­tive on the last use as on the first, and also reduces risk of bac­te­r­ial con­t­a­m­i­na­tion.

Another fea­ture that sets the new prod­uct apart from oth­ers on the mar­ket is the spray appli­ca­tion, rather than a cream, allow­ing eas­ier appli­ca­tion for nurses or care­givers, even dis­tri­b­u­tion on the skin and quicker absorp­tion.

The price of Farmoliva Oleicopiel is lower than sim­i­lar prod­ucts on the mar­ket, which are made with hyper-oxy­genated fatty acids, mak­ing it more acces­si­ble to those who require fre­quent use.

The project was orig­i­nally funded in 2010 by the Andalusian Ministry of Health, but was expanded into var­i­ous health and social cen­tres in the province of Córdoba dur­ing 2011. The pos­i­tive results obtained in the study lead to the reg­is­tra­tion of the patent and the sub­se­quent part­ner­ship with Potosi 10 S.A was formed to develop a mar­ketable prod­uct based on the find­ings of the research. The com­pany was selected for its qual­ity prod­ucts, par­tic­u­lar oil char­ac­ter­is­tics, out­stand­ing lab­o­ra­tory con­di­tions and the fact that it already had an sec­tor ded­i­cated to cos­met­ics.

The mar­ket­ing of Farmoliva Oleicopiel is cur­rently under­way in Andalusia, with brand­ing and design com­pleted and mass mar­ket­ing to hos­pi­tals and health cen­tres through­out the region cur­rently in progress. The prod­uct can be pur­chased through the com­pany head­quar­ters and in selected Spanish phar­ma­cies.


More articles on:  ,

Advertisement
Advertisement

Related Articles